#United States #New York #Levi Korsinsky #stock investigation #FMC Corporation

FMC Corporation Under Investigation

In the wake of substantial declines in stock value, FMC Corporation is now the subject of an investigation initiated by Levi & Korsinsky, LLP. After recently lowering its revenue projections for the third quarter of 2026 from between $840 million and $900 million to a mere $65 million to $125 million, the company's shares plummeted between 31% and 46%. This drastic reset in revenue expectations comes just weeks after the firm raised approximately $403 million by issuing new shares at $13.30 each.

Context of the Situation

On May 19, 2026, FMC Corporation filed a Form 8-K with the SEC regarding its secured notes, revealing that they marketed nearly $1.95 billion in secured notes across the months of May and June. On July 1, 2026, FMC also reported selling new shares to Tessenderlo Group, totaling $403 million. The investigation led by Levi & Korsinsky seeks to determine whether FMC’s disclosures during these fundraising efforts misled investors, especially considering the significant adjustments to their revenue and EBITDA forecasts, which now indicate an adjusted EBITDA loss of $510 million to $565 million.

Implications for Investors

Investors who purchased shares at inflated prices and subsequently suffered losses may find themselves eligible for compensation. The investigation focuses on determining if FMC made any materially false or misleading statements about its business conditions and outlook, particularly regarding disclosures related to its capital raises preceding the revenue guidance cut. As shareholders stand to lose significantly from the stock's downturn, Levi & Korsinsky has urged those affected to come forward and provide their stock purchase details for evaluation.

FAQs About the Investigation

Q: Who can participate in the FMC investigation?
A: Eligible participants include investors who purchased FMC stock or securities and suffered financial losses. It's important that eligibility is based on purchase dates and documented losses rather than current ownership status of the shares.

Q: How much did FMC stock decrease?
A: Following the revision of their revenue guidance, FMC shares dropped abruptly by approximately 31% to 46%.

Q: What statements are under scrutiny?
A: The investigation is examining whether FMC Corporation issued materially false or misleading statements regarding its financial health, focusing on the disclosures linked to the secured notes offerings and their upcoming revenue guidance reduction.

Q: What steps should investors take?
A: Investors are recommended to gather relevant brokerage records that show purchase dates, quantities, and prices of shares. Submitting this information will facilitate a free evaluation regarding potential recovery claims. No fees are incurred unless a case proceeds to court.

The Path Forward

For those impacted by FMC's recent financial hardships, taking timely action is crucial. Interested shareholders are encouraged to reach out to Joseph E. Levi, Esq., for a no-cost, no-obligation assessment of their potential recovery. This investigation highlights the importance of accurate financial disclosures and investor protection in the realm of public companies.

Levi & Korsinsky, LLP, recognized for its advocacy in shareholder rights litigation, has successfully recovered substantial losses for investors in the past. This new development serves as a stark reminder for investors to remain vigilant regarding the accuracy of corporate communications and regulatory filings, particularly during times of volatility in the market.

In conclusion, as FMC navigates this turbulent period, both the company and its shareholders must brace for the potential implications of this investigation and its outcomes.